GALORETX PHARMACEUTICALS PRIVATE LIMITED
GALORETX PHARMACEUTICALS PRIVATE LIMITED is a KARNATAKA based PRIVATE LIMITED company, Registered at dated 12-JUL-2018 on Ministry of Corporate Affairs(MCA), The Corporate Identification Number (CIN) of GALORETX PHARMACEUTICALS PRIVATE LIMITED is U85320KA2018PTC114735 and registration number is 114735.
It has been classified as COMPANY LIMITED BY SHARES and is registered under Registar of Companies BANGALORE India. Authorized share capital of GALORETX PHARMACEUTICALS PRIVATE LIMITED is Rs. 1000000 and its paid up capital is Rs. 100000. It aspire to serve in HEALTH and SOCIAL WORK activities across the India.
Its Annual General Meeting (AGM) was lastly conducted on and as per the records of Ministry of Corporate Affairs (MCA), its balance sheet was last filed on .
GALORETX PHARMACEUTICALS PRIVATE LIMITED has 2 directors RAGHUVEER KALLAJHARI RAMACHANDRA, KALLAJHARI SUBRAHMANYA RAMACHANDRA,
The registered Email address of GALORETX PHARMACEUTICALS PRIVATE LIMITED is admin@galoretx.com and its registered address is #1-1-16(S)1 KALLAJHARI UDUPI UDUPI KA 576102 IN KARNATAKA KARNATAKA india 576102.
The current status of GALORETX PHARMACEUTICALS PRIVATE LIMITED shows as ACTIVE
COMPANY BASIC DETAILS
GALORETX PHARMACEUTICALS PRIVATE LIMITED
BANGALORE
ACTIVE
HEALTH and SOCIAL WORK
U85320KA2018PTC114735
12 JUL 2018
COMPANY LIMITED BY SHARES
NON-GOVERNMENT
PRIVATE
1000000
100000
CONTACT DETAILS
576102
INDIA
#1-1-16(S)1 KALLAJHARI UDUPI UDUPI KA 576102 IN
admin@galoretx.com
DIRECTOR DETAILS
DIN | Director Name | Designation | Appointment Date |
---|---|---|---|
08178693 | RAGHUVEER KALLAJHARI RAMACHANDRA | Director | 12/07/2018 |
08178694 | KALLAJHARI SUBRAHMANYA RAMACHANDRA | Director | 12/07/2018 |
Details Updated by Companies
Quick Links
- All Registered company of KARNATAKA
- Company Registered in KARNATAKA
- All Registered company of UDUPI in KARNATAKA
- Listed Company
- Company Category
- Latest Registered Company
Contact Us for Update Extra Information about your company and services.